Literature DB >> 21930534

OCT4 immunohistochemistry may be necessary to identify the real risk of gonadal tumors in patients with Turner syndrome and Y chromosome sequences.

B A Barros1, S G Moraes, F B Coeli, J G Assumpção, M P De Mello, A T Maciel-Guerra, A B Carvalho, N Viguetti-Campos, T A P Vieira, E M I Amstalden, J G R Andrade, A M Esquiaveto-Aun, A P Marques-de-Faria, L F R D'Souza-Li, S H V Lemos-Marini, G Guerra.   

Abstract

BACKGROUND: The aim of this study was to investigate the frequency of gonadal tumors among patients with Turner syndrome (TS) carrying Y-derivative sequences in their chromosomal constitution.
METHODS: Six out of 260 patients with TS were selected based on mosaicism of the entire Y chromosome; 10 were included because Y-derivative sequences have been detected by PCR with specific oligonucleotides (sex-determining region on the Y, testis specific-protein, Y and DYZ3) and further confirmed by FISH. The 16 patients were subjected to bilateral gonadectomy at ages varying from 8.7 to 18.2 years. Both histopathological investigation with hematoxylin and eosin (H&E) and immunohistochemical analysis with anti-octamer-binding transcription factor 4 (OCT4) antibody were performed.
RESULTS: Gonadal neoplasia was not detected in any of the 32 gonads evaluated by H&E; however, four gonads (12%) from three patients (19%) had positive OCT4 staining in 50-80% of nuclei, suggesting the existence of germ cell tumors (gonadoblastoma or in situ carcinoma).
CONCLUSIONS: Evaluation of the real risk of development of gonadal tumors in TS patients with Y-derivative sequences in their chromosomal constitution may require a specific histopathological study, such as immunohistochemistry with OCT4.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21930534     DOI: 10.1093/humrep/der310

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Risk of Gonadoblastoma Development in Patients with Turner Syndrome with Cryptic Y Chromosome Material.

Authors:  Ahreum Kwon; Sei Eun Hyun; Mo Kyung Jung; Hyun Wook Chae; Woo Jung Lee; Tae Hyuk Kim; Duk Hee Kim; Ho-Seong Kim
Journal:  Horm Cancer       Date:  2017-03-27       Impact factor: 3.869

2.  Identification of Y-Chromosome Sequences in Turner Syndrome.

Authors:  Roseane Lopes da Silva-Grecco; Alessandra Bernadete Trovó-Marqui; Tiago Alves de Sousa; Lilian Da Croce; Marly Aparecida Spadotto Balarin
Journal:  Indian J Pediatr       Date:  2015-12-04       Impact factor: 1.967

3.  Association of immunohistochemical markers with premalignancy in Gonadal Dysgenesis.

Authors:  Bonnie McCann-Crosby; Sheila Gunn; E O'Brian Smith; Lefkothea Karaviti; M John Hicks
Journal:  Int J Pediatr Endocrinol       Date:  2015-06-15

4.  Hyperandrogenism in a girl with Turner syndrome: A case report.

Authors:  Yuchao Diao; Qingmei Zheng; Zhihong Chen; Shuzhen Dai; Qin Yao
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

5.  Hidden Y Chromosome Mosaicism in 48 Egyptian Patients with Turner's Syndrome.

Authors:  Mervat M El-Eshmawy; Sohier Yahia; Faeza A El-Dahtory; Sahar Hamed; El Hadidy M El Hadidy; Mohamed Ragab
Journal:  Genet Res Int       Date:  2013-07-28

Review 6.  [Prevalence of Y-chromosome sequences and gonadoblastoma in Turner syndrome].

Authors:  Alessandra Bernadete Trovó de Marqui; Roseane Lopes da Silva-Grecco; Marly Aparecida Spadotto Balarin
Journal:  Rev Paul Pediatr       Date:  2015-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.